Advanced Search

per page
  Report Title Date Provider Type Pgs Price

Mesoblast Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

16 May 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - MESOBLAST LTD (MSB-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

22 May 2015 Thomson Reuters Stock Report 11 $25.00

ValuEngine Industry Report for Medical-biomed/genetics(MBLTY)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

19 May 2015 ValuEngine, Inc. 10 $49.00

Mesoblast Limited - Diabetic Nephropathy Trial Results Selected for Late-Breaking Presentation at American Diabetes Association Annual Meeting

18 May 2015 2 $23.00

Mesoblast Limited - Mesoblast Cell Therapy Reduces Inflammation and Reverses Coronary Artery Dysfunction in Rheumatoid Arthritis Preclinical Study

12 May 2015 2 $23.00

Is Mesoblast limited Worth a Higher Bid?

12 May 2015 Sadif Analytics Prime 12 $25.00

Wright Investors Service Comprehensive Report for Mesoblast Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

09 May 2015 Wright Reports 55 $75.00

Mesoblast Limited (MSB) - Financial Analysis Review

Mesoblast Limited (MSB) - Financial Analysis Review Summary Mesoblast Limited (Mesoblast) is a biotechnology company. T...

05 May 2015 GlobalData 36 $125.00

Mesoblast Limited - Appendix 3F - Final Share Buy-Back Notice (Except Minimum Holding Buy-Back)

05 May 2015 2 $23.00

Mesoblast Limited - Appendix 3E - Daily Share Buy-Back Notice (Except Minimum Holding Buy-Back and Selective Buy-Back)

05 May 2015 3 $35.00